Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Do LPL and LIPC genetic variants influence HDL particle size and remodeling?

Genetic variation in LPL and LIPC alters HDL particle size and drives changes in HDL remodeling, with smaller HDL size linked to less favorable remodeling in certain contexts.

PlausibleJune 22, 202615 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Lipoprotein lipase and hepatic lipase genetic variation can influence HDL particle size and lipid remodeling, and smaller HDL size is associated with less favorable lipoprotein remodeling patterns.

laying out figure…
1 of 3 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that functional LPL variants promote transfer of surface lipids to HDL enlarging particles, while reduced hepatic lipase activity from LIPC variants leads to accumulation of larger HDL2, together shaping HDL architecture. It also notes that smaller HDL particles are efficient for ABCA1-mediated cholesterol efflux under healthy conditions but can become triglyceride-rich and dysfunctional in insulin resistance or hypertriglyceridemia, making the clinical impact context-dependent.

Verified conclusion

Human lipid metabolism is highly regulated by key enzymatic pathways where genetic variations significantly shape lipoprotein architecture and vascular health.

Genetic and molecular mechanisms

  • LPL-mediated enlargement: The gain-of-function LPL S447X (rs328) variant enhances lipolysis of chylomicrons and VLDL, transferring surface lipids to HDL and promoting its enlargement into buoyant HDL2 subclasses. Conversely, loss-of-function LPL variants limit this transfer, favoring smaller, denser HDL3.
  • LIPC-mediated reduction: Hepatic lipase, encoded by LIPC, hydrolyzes lipids on large HDL to convert them back to smaller HDL3. The promoter variant rs1800588 (−514C>T) reduces hepatic lipase activity, leading to an accumulation of large, cholesterol-rich HDL2 particles.
  • Efflux capacity: Smaller HDL particles are highly efficient, physiologically active intermediates that promote reverse cholesterol transport by increasing ABCA1-mediated cholesterol efflux.

Clinical and metabolic implications

  • Physiological vs. pathological remodeling: Under healthy conditions, smaller HDL particles are cardioprotective and highly active in reverse cholesterol transport. However, in states of insulin resistance and hypertriglyceridemia, HDL undergoes aberrant remodeling into small, triglyceride-rich, protein-modified particles that are functionally impaired.
  • Context-dependent remodeling: Physical HDL size alone is an incomplete clinical surrogate. Small HDL size is associated with unfavorable remodeling specifically when embedded within a dyslipidemic milieu, whereas physiologically small HDL remains highly functional.

Bottom line

  • Key takeaway: Genetic variations in LPL and LIPC directly drive HDL remodeling and particle size. While smaller HDL particles are physiologically vital for ABCA1-mediated cholesterol efflux, pathological states like insulin resistance remodel them into dysfunctional, triglyceride-rich particles, making the clinical impact of HDL size highly context-dependent.

References

  1. Lipoprotein lipase gene sequencing and plasma lipid profile - PMC — pmc.ncbi.nlm.nih.gov ↗
  2. LIPC variants in the promoter and intron 1 modify HDL-C levels in a ... — pmc.ncbi.nlm.nih.gov ↗
  3. Hepatic lipase gene -514C>T variant is associated with exercise ... — pmc.ncbi.nlm.nih.gov ↗
  4. LIPC gene Lipase C, Hepatic Type - GeneCards — genecards.org ↗
  5. High-density lipoprotein subpopulation profiles in lipoprotein lipase ... — pmc.ncbi.nlm.nih.gov ↗
  6. Lipoprotein lipase and hepatic lipase: their relationship with HDL ... — pmc.ncbi.nlm.nih.gov ↗
  7. Conventional HDL Subclass Measurements Mask Thyroid Hormone-dependent Remodeling Activity Sites in Hypothyroid Individuals — academic.oup.com ↗
  8. Joint linkage and association analysis of the hepatic lipase promoter ... — texasbiomedical.theopenscholar.com ↗
  9. Joint Linkage and Association Analysis of the Hepatic Lipase ... — pubmed.ncbi.nlm.nih.gov ↗
  10. Association of CETP and LIPC Gene Polymorphisms with HDL and ... — pmc.ncbi.nlm.nih.gov ↗
  11. Promoter polymorphisms of hepatic lipase gene influence HDL2 but ... — sciencedirect.com ↗
  12. Promoter polymorphisms of hepatic lipase gene influence HDL(2 ... — pubmed.ncbi.nlm.nih.gov ↗
  13. HDL Particle Size and Functional Heterogeneity - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  14. HDL particle subpopulations: Focus on biological function — iubmb.onlinelibrary.wiley.com ↗
  15. Flipped C-Terminal Ends of APOA1 Promote ABCA1-dependent Cholesterol Efflux by Small HDLs — ahajournals.org ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→